These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
471 related articles for article (PubMed ID: 24203492)
21. Effect of platinum‑based chemotherapy on the expression of natural killer group 2 member D ligands, programmed cell death‑1 ligand 1 and HLA class I in non‑small cell lung cancer. Okita R; Maeda A; Shimizu K; Nojima Y; Saisho S; Nakata M Oncol Rep; 2019 Aug; 42(2):839-848. PubMed ID: 31173242 [TBL] [Abstract][Full Text] [Related]
22. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells. Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909 [TBL] [Abstract][Full Text] [Related]
23. Identification and functional analysis of ligands for natural killer cell activating receptors in colon carcinoma. Zhang Z; Su T; He L; Wang H; Ji G; Liu X; Zhang Y; Dong G Tohoku J Exp Med; 2012 Jan; 226(1):59-68. PubMed ID: 22189020 [TBL] [Abstract][Full Text] [Related]
24. Synergistic enhancement of NK cell-mediated cytotoxicity by combination of histone deacetylase inhibitor and ionizing radiation. Son CH; Keum JH; Yang K; Nam J; Kim MJ; Kim SH; Kang CD; Oh SO; Kim CD; Park YS; Bae J Radiat Oncol; 2014 Feb; 9():49. PubMed ID: 24512718 [TBL] [Abstract][Full Text] [Related]
25. Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2. Textor S; Fiegler N; Arnold A; Porgador A; Hofmann TG; Cerwenka A Cancer Res; 2011 Sep; 71(18):5998-6009. PubMed ID: 21764762 [TBL] [Abstract][Full Text] [Related]
26. Quercetin enhances susceptibility to NK cell-mediated lysis of tumor cells through induction of NKG2D ligands and suppression of HSP70. Bae JH; Kim JY; Kim MJ; Chang SH; Park YS; Son CH; Park SJ; Chung JS; Lee EY; Kim SH; Kang CD J Immunother; 2010 May; 33(4):391-401. PubMed ID: 20386467 [TBL] [Abstract][Full Text] [Related]
27. Varicella-Zoster Virus and Herpes Simplex Virus 1 Differentially Modulate NKG2D Ligand Expression during Productive Infection. Campbell TM; McSharry BP; Steain M; Slobedman B; Abendroth A J Virol; 2015 Aug; 89(15):7932-43. PubMed ID: 25995251 [TBL] [Abstract][Full Text] [Related]
28. Modulation of NKG2D ligand expression and metastasis in tumors by spironolactone via RXRγ activation. Leung WH; Vong QP; Lin W; Janke L; Chen T; Leung W J Exp Med; 2013 Nov; 210(12):2675-92. PubMed ID: 24190430 [TBL] [Abstract][Full Text] [Related]
29. DNA demethylation and histone H3K9 acetylation determine the active transcription of the NKG2D gene in human CD8+ T and NK cells. Fernández-Sánchez A; Baragaño Raneros A; Carvajal Palao R; Sanz AB; Ortiz A; Ortega F; Suárez-Álvarez B; López-Larrea C Epigenetics; 2013 Jan; 8(1):66-78. PubMed ID: 23235109 [TBL] [Abstract][Full Text] [Related]
30. Histone Deacetylase Inhibitor Modulates NKG2D Receptor Expression and Memory Phenotype of Human Gamma/Delta T Cells Upon Interaction With Tumor Cells. Bhat J; Dubin S; Dananberg A; Quabius ES; Fritsch J; Dowds CM; Saxena A; Chitadze G; Lettau M; Kabelitz D Front Immunol; 2019; 10():569. PubMed ID: 30972064 [TBL] [Abstract][Full Text] [Related]
31. [Matrine enhances the cytotoxic sensitivity of ABCG2high nasopharyngeal carcinoma cells to natural killer cells by inducing high expression of NKG2D receptor ligands]. Huang YX; Wang Y; Sun M; Zhou XY; Deng L; Guo KY Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jul; 29(7):1329-32. PubMed ID: 19620045 [TBL] [Abstract][Full Text] [Related]
32. Induction of NKG2D ligands and increased sensitivity of tumor cells to NK cell-mediated cytotoxicity by hematoporphyrin-based photodynamic therapy. Park MJ; Bae JH; Chung JS; Kim SH; Kang CD Immunol Invest; 2011; 40(4):367-82. PubMed ID: 21314289 [TBL] [Abstract][Full Text] [Related]
33. The human NKG2D ligand ULBP2 can be expressed at the cell surface with or without a GPI anchor and both forms can activate NK cells. Fernández-Messina L; Ashiru O; Agüera-González S; Reyburn HT; Valés-Gómez M J Cell Sci; 2011 Feb; 124(Pt 3):321-7. PubMed ID: 21224393 [TBL] [Abstract][Full Text] [Related]
35. Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein. Rölle A; Mousavi-Jazi M; Eriksson M; Odeberg J; Söderberg-Nauclér C; Cosman D; Kärre K; Cerboni C J Immunol; 2003 Jul; 171(2):902-8. PubMed ID: 12847260 [TBL] [Abstract][Full Text] [Related]
36. Interleukin-18 synergism with interleukin-2 in cytotoxicity and NKG2D expression of human natural killer cells. Qi YY; Lu C; Ju Y; Wang ZE; Li YT; Shen YJ; Lu ZM Asian Pac J Cancer Prev; 2014; 15(18):7857-61. PubMed ID: 25292077 [TBL] [Abstract][Full Text] [Related]
37. A bispecific protein rG7S-MICA recruits natural killer cells and enhances NKG2D-mediated immunosurveillance against hepatocellular carcinoma. Wang T; Sun F; Xie W; Tang M; He H; Jia X; Tian X; Wang M; Zhang J Cancer Lett; 2016 Mar; 372(2):166-78. PubMed ID: 26791237 [TBL] [Abstract][Full Text] [Related]
38. A dual function of NKG2D ligands in NK-cell activation. Cheney EE; Wise EL; Bui JD; Schreiber RD; Carayannopoulos LN; Spitzer D; Zafirova B; Polic B; Shaw AS; Markiewicz MA Eur J Immunol; 2012 Sep; 42(9):2452-8. PubMed ID: 22740149 [TBL] [Abstract][Full Text] [Related]
39. c-Cbl regulates MICA- but not ULBP2-induced NKG2D down-modulation in human NK cells. Molfetta R; Quatrini L; Capuano C; Gasparrini F; Zitti B; Zingoni A; Galandrini R; Santoni A; Paolini R Eur J Immunol; 2014 Sep; 44(9):2761-70. PubMed ID: 24846123 [TBL] [Abstract][Full Text] [Related]
40. Sodium butyrate upregulates expression of NKG2D ligand MICA/B in HeLa and HepG2 cell lines and increases their susceptibility to NK lysis. Zhang C; Wang Y; Zhou Z; Zhang J; Tian Z Cancer Immunol Immunother; 2009 Aug; 58(8):1275-85. PubMed ID: 19139882 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]